MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$6,930,653
EPS
-$0.57
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
Research and development
4,557,383
4,129,102*
2,523,305
General and administrative
2,638,629
2,518,404.5*
2,327,391
Total operating expenses
7,196,012
6,647,506.5
4,850,696
Loss from operations
-7,196,012
-6,647,506.5*
-4,850,696
Loss (gain) on valuation of warrants
-132,000
440,104*
-294,276
Interest income
133,359
134,255.5*
112,543
Total other income (expense)
265,359
-305,848.5*
406,819
Loss before income taxes
-6,930,653
-6,953,355
-
Net loss
-6,930,653
-6,953,355
-4,443,877
Basic EPS
-0.57
-2.666
-1.41
Diluted EPS
-0.57
-2.666
-1.41
Basic Average Shares
12,231,851
2,608,317*
3,162,040
Diluted Average Shares
12,231,851
2,608,317*
3,162,040
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$6,930,653
(-27.22%↓ Y/Y)
Interest income
$133,359
(51.51%↑ Y/Y)
Loss (gain) on
valuation of warrants
-$132,000
(73.68%↑ Y/Y)
Loss before income
taxes
-$6,930,653
Total other income
(expense)
$265,359
(-54.99%↓ Y/Y)
Loss from operations
-$7,196,012
(-19.19%↓ Y/Y)
Total operating
expenses
$7,196,012
(19.19%↑ Y/Y)
Research and development
$4,557,383
(90.70%↑ Y/Y)
General and
administrative
$2,638,629
(-27.66%↓ Y/Y)
Buy us a coffee
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)